PFIZER INC

PFE - CIK 0000078003

Market cap$146.15 B

Rank#105

SEC filings985

PFIZER INC trades as PFE and has a market capitalization of $146.15 B, making it the #105 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $62.58B, down 1.6% from the prior year and net income of $7.77B. This page tracks PFIZER INC through 985 SEC filings, with financial statements and metrics updated as new reports are filed.

Key metrics

Revenue (latest FY)$62.58BFY 2025

Net income (latest FY)$7.77BFY 2025

Operating cash flow (latest FY)$11.70BFY 2025

Total assets (latest FY)$208.16BFY 2025

Net margin12.4%latest FY

Financial performance

Over the last 9 fiscal years PFIZER INC's revenue grew from $52.82B to $62.58B, a compound annual growth rate of 1.9%. Net profit margin compressed from 13.7% to 12.4% over the same period - every figure below comes from the company's audited annual filings.

PFE annual revenueView details

Key statistics

Market cap: $146.15 B
Share price (derived)market cap / shares outstanding: $25.64
P/E ratio (trailing FY): 18.8
EPS (diluted)FY 2025: $1.36
Shares outstandingas of 2026-04-29: 5.70B
Total equityas of 2026-03-29: $90.10B
Return on equity: 8.6%
Long-term debtas of 2026-03-29: $60.56B

Latest filings

Filing	Type	Filed
Insider trade	4	2026-05-18
SCHEDULE 13G/A	-	2026-05-12
Institutional holdings	13F-HR	2026-05-12
Employee stock plan	S-8	2026-05-05
Quarterly report	10-Q	2026-05-05
Major company event	8-K	2026-05-05
Insider trade	4	2026-05-04
SCHEDULE 13G	-	2026-05-01

Browse the full filing history (985 filings)

Recent press releases

Pfizer Declares Second-Quarter 2026 Dividend
(NYSE: PFE) today announced that its board of directors declared a $0.43 second-quarter 2026 dividend on the company's common stock, payable ...
Pfizer Announces 2026 Shareholder Meeting Preliminary Results
Preliminary results from the Annual Meeting indicate that the shareholders: reelected the company's 12 director nominees to one-year terms; ...